ZimVie Inc. (ZIMV)

NASDAQ: ZIMV · IEX Real-Time Price · USD
16.49
+0.18 (1.10%)
Mar 28, 2024, 4:00 PM EDT - Market closed
1.10%
Market Cap 446.61M
Revenue (ttm) 457.43M
Net Income (ttm) -393.28M
Shares Out 27.08M
EPS (ttm) -14.87
PE Ratio n/a
Forward PE 150.39
Dividend n/a
Ex-Dividend Date n/a
Volume 580,039
Open 16.53
Previous Close 16.31
Day's Range 16.06 - 16.75
52-Week Range 6.52 - 20.91
Beta 2.03
Analysts Hold
Price Target 16.00 (-2.97%)
Earnings Date May 1, 2024

About ZIMV

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the Be... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2021
Employees 2,600
Stock Exchange NASDAQ
Ticker Symbol ZIMV
Full Company Profile

Financial Performance

In 2023, ZimVie's revenue was $457.43 million, a decrease of -1.26% compared to the previous year's $463.29 million. Losses were -$393.28 million, 515.6% more than in 2022.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for ZIMV stock is "Hold." The 12-month stock price forecast is $16.0, which is a decrease of -2.97% from the latest price.

Price Target
$16.0
(-2.97% downside)
Analyst Consensus: Hold
Stock Forecasts

News

ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference

WESTMINSTER, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced management will participate in the upc...

2 days ago - GlobeNewsWire

ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

WESTMINSTER, Colo., Feb. 21, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the four...

5 weeks ago - GlobeNewsWire

ZimVie Announces Launch of Next-Generation TSX® Implant in Japan

Newest implant innovation is designed for immediacy and peri-implant health Newest implant innovation is designed for immediacy and peri-implant health

7 weeks ago - GlobeNewsWire

ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc

WESTMINSTER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the first patient in the United St...

5 months ago - GlobeNewsWire

ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions

New offerings expand ZimVie's dental solutions for lab customers, enhancing selection and broadening the reach of the ZimVie portfolio New offerings expand ZimVie's dental solutions for lab customers,...

5 months ago - GlobeNewsWire

ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023

WESTMINSTER, Colo., Oct. 11, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the thir...

6 months ago - GlobeNewsWire

ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane

New offering broadens ZimVie's dental portfolio into the expanding growth factor biomaterials market New offering broadens ZimVie's dental portfolio into the expanding growth factor biomaterials marke...

6 months ago - GlobeNewsWire

ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study

Decision clears the way for enrollment of U.S. patients in a groundbreaking clinical study of cervical arthroplasty adjacent to fusion Decision clears the way for enrollment of U.S. patients in a grou...

6 months ago - GlobeNewsWire

ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing

ZimVie and Brainlab will cooperate on achieving compatibility between ZimVie's Vital™ and Virage ® fixation systems with the Brainlab spine and trauma technologies for global co-marketing purposes

8 months ago - GlobeNewsWire

ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance

WESTMINSTER, Colo., Aug. 02, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today reported financial results for the second quarter...

8 months ago - GlobeNewsWire

ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023

WESTMINSTER, Colo., July 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the seco...

9 months ago - GlobeNewsWire

ZimVie to Present at the Stifel 2023 Jaws & Paws Conference

WESTMINSTER, Colo., May 22, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the company will be participating i...

11 months ago - GlobeNewsWire

ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug

New offerings in ZimVie's extensive portfolio of dental bone graft solutions enhance selection for customers and bolster cadence of recent product launches New offerings in ZimVie's extensive portfoli...

1 year ago - GlobeNewsWire

ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023

WESTMINSTER, Colo., April 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fir...

1 year ago - GlobeNewsWire

ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®

Mobi-C obtains French government reimbursement and the highest quality rating from the British clinical data panel ODEP Mobi-C obtains French government reimbursement and the highest quality rating fr...

1 year ago - GlobeNewsWire

ZimVie's Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants

Publication highlights Puros Cancellous Particulate Allograft's collagen microstructure and greater surface area for significantly higher mesenchymal stromal cellular (hBMSC) response compared to comp...

1 year ago - GlobeNewsWire

ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering

The Tether™ device now deemed “medically necessary” for the treatment of pediatric scoliosis in additional patients covered by Highmark and BCBS North Dakota The Tether™ device now deemed “medically n...

1 year ago - GlobeNewsWire

ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results

WESTMINSTER, Colo., March 01, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today reported financial results for the fourth quarte...

1 year ago - GlobeNewsWire

ZimVie Announces Launch of the RealGUIDE™ CAD and FULL SUITE Software Modules

Two innovations enhancing ZimVie's digital dentistry platform Two innovations enhancing ZimVie's digital dentistry platform

1 year ago - GlobeNewsWire

ZimVie to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023

WESTMINSTER, Colo., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the four...

1 year ago - GlobeNewsWire

ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®

Milestone aligns with ten-year anniversary of Mobi-C FDA approval for treatment of one and two levels of the cervical spine Milestone aligns with ten-year anniversary of Mobi-C FDA approval for treatm...

1 year ago - GlobeNewsWire

ZimVie to Present at the 41st Annual J.P. Morgan Healthcare Conference

WESTMINSTER, Colo., Dec. 28, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that management will present at the 41s...

1 year ago - GlobeNewsWire

ZimVie Announces Launch of Next-Generation TSX™ Implant in the United States

Newest innovation in ZimVie's digital dentistry platform is designed for immediacy and peri-implant health Newest innovation in ZimVie's digital dentistry platform is designed for immediacy and peri-i...

1 year ago - GlobeNewsWire

ZimVie to Report Third Quarter 2022 Financial Results on November 9, 2022

WESTMINSTER, Colo., Oct. 19, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the thir...

1 year ago - GlobeNewsWire

ZimVie Expands Navigation-Compatible Platform to Include Posterior Cervical Application

The Virage® Navigation System Rounds out ZimVie's Ability to Navigate Pedicle Screws in the Entire Spine The Virage® Navigation System Rounds out ZimVie's Ability to Navigate Pedicle Screws in the Ent...

1 year ago - GlobeNewsWire